Biomarker Antibodies Designed to Detect Cancer

Abcam has extended its range of cancer biomarker antibodies by entering into an agreement with Spring Bioscience, which has produced an array of immunohistochemistry (IHC)-optimized recombinant rabbit monoclonal SP clones. This has enlarged their range of antibodies, with 1,300 more gold standard IHC-suitable antibodies against cancer biomarkers now available.

Advantages

This new development has numerous advantages, such as:

  • The ability to target isolated cancer biomarkers and pathologic markers
  • Includes some of the most commonly used SP clone monoclonal rabbit antibodies reported in scientific literature
  • Includes antibodies that have been optimized especially for use in IHC experiments
Target name Clone ID Spring catalog ID Abcam catalog ID
PD-L1/CD274 SP142 M4420 ab228462
BRAF V600E VE1 E19290 ab228461
Cleaved PTEN SP227 M5275 ab227674
(D301)
GIV (pY1765) SP158 M4584 ab130424
ALDH1A1 SP297 M6974 ab227693
B7-H3/CD276 SP265 M5650 ab227679
c-Met SP44 M3440 ab227637
FGFR2 SP273 M5730 ab227683
GPNMB SP299 M5990 ab227695
HER-3 SPM738 E19261 ab228028
IDO-1 SP282 M5820 ab228472
LIV-1 SP300 M6000 ab227696
OX-40 SP195 M4950 ab228464
PDHK1 SP270 M5700 ab227682
PTEN SP218 M5180 ab228466
SATB2 SP281 M5810 ab227686
SOX-10 SP267 M5670
ab227680
​ab227680
TROP-2 SP293 M5930 ab227689
FAP SP325 M6250 ab227703

About Abcam

Abcam is a global life sciences company providing highly validated antibodies and other binders and assays to the research and clinical communities to help advance the understanding of biology and causes of disease.

Abcam’s mission is to serve life scientists to help them achieve their mission faster by listening to their needs, continuously innovating and improving and by giving them the tools, data and experience they want. Abcam’s ambition is to become the most influential life science company for researchers worldwide.


Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.

Last updated: May 15, 2019 at 8:51 AM

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Abcam. (2019, May 15). Biomarker Antibodies Designed to Detect Cancer. News-Medical. Retrieved on September 24, 2019 from https://www.news-medical.net/whitepaper/20190515/Biomarker-Antibodies-Designed-to-Detect-Cancer.aspx.

  • MLA

    Abcam. "Biomarker Antibodies Designed to Detect Cancer". News-Medical. 24 September 2019. <https://www.news-medical.net/whitepaper/20190515/Biomarker-Antibodies-Designed-to-Detect-Cancer.aspx>.

  • Chicago

    Abcam. "Biomarker Antibodies Designed to Detect Cancer". News-Medical. https://www.news-medical.net/whitepaper/20190515/Biomarker-Antibodies-Designed-to-Detect-Cancer.aspx. (accessed September 24, 2019).

  • Harvard

    Abcam. 2019. Biomarker Antibodies Designed to Detect Cancer. News-Medical, viewed 24 September 2019, https://www.news-medical.net/whitepaper/20190515/Biomarker-Antibodies-Designed-to-Detect-Cancer.aspx.

Other White Papers by this Supplier